GHA
MDT icon

GW Henssler & Associates’s Medtronic MDT Stock Holding History

GW Henssler & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.54M Buy
121,925
+9,500
+8% +$766K 0.42% 81
2026
Q1 		$9.74M Buy
+112,425
New +$10.8M 0.46% 85
2024
Q3 		– Sell
-273,599
Closed -$21.5M – 208
2024
Q2 		$21.5M Buy
273,599
+730
+0.3% +$59.8K 1.3% 32
2024
Q1 		$23.8M Buy
272,869
+17,108
+7% +$1.46M 1.4% 28
2023
Q4 		$21.1M Sell
255,761
-16,682
-6% -$1.27M 1.39% 29
2023
Q3 		$21.3M Sell
272,443
-93
-0% -$7.79K 1.46% 26
2023
Q2 		$24M Buy
272,536
+3,118
+1% +$268K 1.58% 21
2023
Q1 		$21.7M Buy
269,418
+156,620
+139% +$12.8M 1.44% 26
2022
Q4 		$8.77M Sell
112,798
-50,595
-31% -$4.1M 0.62% 56
2022
Q3 		$13.2M Buy
163,393
+36,699
+29% +$3.3M 0.99% 46
2022
Q2 		$11.4M Sell
126,694
-54,090
-30% -$5.48M 0.84% 51
2022
Q1 		$20.1M Buy
+180,784
New +$19.1M 1.22% 30

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GW Henssler & Associates's MDT Position: Q2 2026 in Review

GW Henssler & Associates increased its Medtronic (MDT) stake by 8.5% in Q2 2026, buying an estimated $766K and bringing the position to 121,925 shares worth $9.54M. The position accounts for 0.42% of the portfolio, ranked #81.

GW Henssler & Associates first reported a position in MDT in Q1 2022 and has held it in 12 quarters since. The position peaked at $24M in Q2 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • GW Henssler & Associates held 121,925 shares of Medtronic worth $9.54M as of Q2 2026.
  • GW Henssler & Associates bought 9,500 Medtronic shares in Q2 2026, an estimated $766K.
  • Medtronic made up 0.42% of GW Henssler & Associates's portfolio in Q2 2026, its #81 holding.
  • GW Henssler & Associates first reported a position in Medtronic in Q1 2022 and has held it in 12 quarters since.
  • GW Henssler & Associates's Medtronic position peaked at $24M in Q2 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.